Stout R D, Murphy D B, McDevitt H O, Herzenberg L A
J Exp Med. 1977 Jan 1;145(1):187-203. doi: 10.1084/jem.145.1.187.
Treatment of splenic T lymphocytes with anti-Ia antiserum inhibits the binding of antigen-antibody (AgAb) complexes to the majority (less than 50%) of Fc receptor-positive (FcR+) T cells. A similar inhibition was observed with anti-H-2D and anti-H-2K sera but not with anti-Thy 1.2. Despite the presence of Ia determinants on peripheral T cells, as established by the inhibition of AgAb binding, Ia could not be detected on peripheral T cells by immunofluorescence assays. Data obtained with the AgAb-binding inhibition assay indicate that determinants controlled by loci mapping in the I-A and I-C, S, or G regions are present on the FcR+ T cells. Evidence is presented that subpopulations of T cells within the FcR+ T-cell population may be distinguishable on the basis of which I-region-controlled determinant is expressed. The data are discussed in terms of phenotypic and functional heterogeneity of T lymphocytes.
用抗Ia抗血清处理脾T淋巴细胞可抑制抗原-抗体(AgAb)复合物与大多数(少于50%)Fc受体阳性(FcR+)T细胞的结合。用抗H-2D和抗H-2K血清观察到类似的抑制作用,但抗Thy 1.2则无此作用。尽管通过AgAb结合抑制已证实外周T细胞上存在Ia决定簇,但通过免疫荧光测定在外周T细胞上未能检测到Ia。用AgAb结合抑制试验获得的数据表明,位于I-A和I-C、S或G区域的基因座所控制的决定簇存在于FcR+ T细胞上。有证据表明,FcR+ T细胞群体内的T细胞亚群可能根据所表达的I区域控制的决定簇而区分。根据T淋巴细胞的表型和功能异质性对这些数据进行了讨论。